Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (Lumateperone, Placebo)

Recruiting
  • Major Depressive Disorder
  • Pico Rivera, California
  • +17 more
May 9, 2023

Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

Completed
  • Migraine
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +63 more
Dec 7, 2022

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Rumination, MDD, Anxiety Trial in Philadelphia (Transcranial Magnetic Stimulation)

Not yet recruiting
  • Rumination
  • +2 more
  • Transcranial Magnetic Stimulation
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 23, 2022

MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)

Completed
Has Results
  • Major Depressive Disorder
  • PNB01 fixed dose combination of pipamperone and citalopram
  • +2 more
  • Glendale, California
  • +30 more
Mar 14, 2022

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

Depressive Disorder, Depression, Depressive Disorder, Major Trial in United States (Synchronized Transcranial Magnetic

Completed
Has Results
  • Depressive Disorder
  • +4 more
  • Synchronized Transcranial Magnetic Stimulation (sTMS)
  • Sham Stimulation
  • La Jolla, California
  • +13 more
Aug 9, 2021

Nicotine Dependence, MDD Trial in Chicago, Philadelphia (Varenicline, BASC, Standard treatment)

Completed
Has Results
  • Nicotine Dependence
  • Major Depressive Disorder
  • Chicago, Illinois
  • +1 more
Jul 27, 2021

Post Traumatic Stress Disorder, MDD Trial in Philadelphia (Theta-burst stimulation)

Active, not recruiting
  • Post Traumatic Stress Disorder
  • Major Depressive Disorder
  • Theta-burst stimulation
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 24, 2021

MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)

Terminated
Has Results
  • Major Depressive Disorder
  • SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
  • Birmingham, Alabama
  • +211 more
Jun 9, 2021

MDD Trial in Worldwide (Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg, Antidepressant + SPD489 (Lisdexamfetamine

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
  • +4 more
  • Little Rock, Arkansas
  • +81 more
May 25, 2021

MDD Trial in United States (CP-601,927, Placebo)

Terminated
Has Results
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +57 more
Apr 7, 2021

MDD Trial in United States (Vortioxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +44 more
Dec 16, 2020

MDD Trial in United States (agomelatine, )

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +77 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Agomelatine, paroxetine, )

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +46 more
Dec 15, 2020

MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))

Completed
Has Results
  • Major Depressive Disorder
  • Assay-guided treatment (AGT)
  • Treatment-as-usual (TAU)
  • Birmingham, Alabama
  • +22 more
Aug 27, 2020

MDD Trial in United States (Esketamine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +13 more
May 7, 2020

MDD, Soft Tissue Discomfort Syndrome, Pain Trial in Philadelphia (Duloxetine)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • Philadelphia, Pennsylvania
    Depression Research Unit, University of Pennsylvania School of M
Apr 3, 2020

MDD Trial in Philadelphia (behavioral activation, treatment-as-usual)

Completed
  • Major Depressive Disorder
  • behavioral activation
  • treatment-as-usual
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 23, 2020

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
Has Results
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

MDD Trial in United States (Placebo, Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Imperial, California
  • +51 more
Dec 6, 2019

MDD Trial in Australia, Canada, United States (High Dose ALKS 5461, Low Dose ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • High Dose ALKS 5461
  • +2 more
  • Birmingham, Alabama
  • +48 more
Aug 2, 2019

MDD Trial in Bulgaria, United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Little Rock, Arkansas
  • +57 more
May 31, 2019